Elixinol Wellness Ltd (ASX:EXL, OTCQB:ELLXF)'s Oliver Horn gives the business case for the company's consumer-centric CBD offering. He says the company is focused on the US market and is also developing its hemp foods arm for health-conscious consumers around the world. Recently, Elixinol inked a licence agreement with British Cannabis to expand its distribution footprint in the UK. The partnership will see the ASX-lister team up with the largest and most established British cannabis producer — a branded goods marketing company and white label manufacturer that Oliver claims is the leading authority in the field.
Elixinol Wellness inks licence agreement with UK's leading cannabis producer
